Search

David M Naff

Examiner (ID: 17706)

Most Active Art Unit
1651
Art Unit(s)
1302, 1643, 1657, 1208, 1808, 1207, 1803, 1802, 1651, 2899
Total Applications
2218
Issued Applications
1396
Pending Applications
143
Abandoned Applications
679

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 11581677 [patent_doc_number] => 09636297 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-05-02 [patent_title] => 'Extemporaneous care product based on a lyophilizate of microorganisms and surfactant(s) with an HLB greater than or equal to 12' [patent_app_type] => utility [patent_app_number] => 12/990414 [patent_app_country] => US [patent_app_date] => 2009-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 3 [patent_no_of_words] => 14670 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 284 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12990414 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/990414
Extemporaneous care product based on a lyophilizate of microorganisms and surfactant(s) with an HLB greater than or equal to 12 Apr 27, 2009 Issued
Array ( [id] => 5495454 [patent_doc_number] => 20090263482 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'Treatment of inflammatory bowel disease with 6-mercaptopurine' [patent_app_type] => utility [patent_app_number] => 12/386611 [patent_app_country] => US [patent_app_date] => 2009-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9566 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20090263482.pdf [firstpage_image] =>[orig_patent_app_number] => 12386611 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/386611
Treatment of inflammatory bowel disease with 6-mercaptopurine Apr 19, 2009 Abandoned
Array ( [id] => 6517939 [patent_doc_number] => 20100261737 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'Method of Treating Erectile Dysfunction' [patent_app_type] => utility [patent_app_number] => 12/421768 [patent_app_country] => US [patent_app_date] => 2009-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2573 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20100261737.pdf [firstpage_image] =>[orig_patent_app_number] => 12421768 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/421768
Method of Treating Erectile Dysfunction Apr 9, 2009 Abandoned
Array ( [id] => 6046868 [patent_doc_number] => 20110206739 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE PREPARATION OF NANOEMULSIONS' [patent_app_type] => utility [patent_app_number] => 12/935180 [patent_app_country] => US [patent_app_date] => 2009-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 22943 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0206/20110206739.pdf [firstpage_image] =>[orig_patent_app_number] => 12935180 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/935180
COMPOSITIONS AND METHODS FOR THE PREPARATION OF NANOEMULSIONS Mar 29, 2009 Abandoned
Array ( [id] => 6328585 [patent_doc_number] => 20100197790 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'CONTAINER FOR PHARMACEUTICAL USE FOR THE QUANTITATIVE RELEASE OF A SINGLE DOSE FOR ORAL ADMINISTRATION OF T3 AND T4 THYROID HORMONES IN SOLUTION' [patent_app_type] => utility [patent_app_number] => 12/388691 [patent_app_country] => US [patent_app_date] => 2009-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3778 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20100197790.pdf [firstpage_image] =>[orig_patent_app_number] => 12388691 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/388691
CONTAINER FOR PHARMACEUTICAL USE FOR THE QUANTITATIVE RELEASE OF A SINGLE DOSE FOR ORAL ADMINISTRATION OF T3 AND T4 THYROID HORMONES IN SOLUTION Feb 18, 2009 Abandoned
Array ( [id] => 5473110 [patent_doc_number] => 20090246276 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'Pharmaceutical Compositions' [patent_app_type] => utility [patent_app_number] => 12/360673 [patent_app_country] => US [patent_app_date] => 2009-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 73 [patent_figures_cnt] => 73 [patent_no_of_words] => 55462 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20090246276.pdf [firstpage_image] =>[orig_patent_app_number] => 12360673 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/360673
Pharmaceutical Compositions Jan 26, 2009 Abandoned
Array ( [id] => 11217665 [patent_doc_number] => 09445984 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-09-20 [patent_title] => 'Two-part cosmetic product with swelling effect to biological surfaces' [patent_app_type] => utility [patent_app_number] => 12/866971 [patent_app_country] => US [patent_app_date] => 2009-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5812 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 231 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12866971 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/866971
Two-part cosmetic product with swelling effect to biological surfaces Jan 21, 2009 Issued
Array ( [id] => 5379292 [patent_doc_number] => 20090191131 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'USE OF PARTICULATE CONTRAST AGENTS IN DIAGNOSTIC IMAGING FOR STUDYING PHYSIOLOGICAL PARAMATERS' [patent_app_type] => utility [patent_app_number] => 12/354275 [patent_app_country] => US [patent_app_date] => 2009-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 19660 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20090191131.pdf [firstpage_image] =>[orig_patent_app_number] => 12354275 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/354275
USE OF PARTICULATE CONTRAST AGENTS IN DIAGNOSTIC IMAGING FOR STUDYING PHYSIOLOGICAL PARAMATERS Jan 14, 2009 Abandoned
Array ( [id] => 6479408 [patent_doc_number] => 20100285152 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'COMPOSITION FOR IMPROVING LIVER METABOLISM AND DIAGNOSTIC METHOD' [patent_app_type] => utility [patent_app_number] => 12/811266 [patent_app_country] => US [patent_app_date] => 2008-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5561 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20100285152.pdf [firstpage_image] =>[orig_patent_app_number] => 12811266 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/811266
COMPOSITION FOR IMPROVING LIVER METABOLISM AND DIAGNOSTIC METHOD Dec 30, 2008 Abandoned
Array ( [id] => 5355585 [patent_doc_number] => 20090186929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-23 [patent_title] => 'Method and agent for inducing apoptosis/cell death in leukemia cells' [patent_app_type] => utility [patent_app_number] => 12/318349 [patent_app_country] => US [patent_app_date] => 2008-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15123 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20090186929.pdf [firstpage_image] =>[orig_patent_app_number] => 12318349 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/318349
Method and agent for inducing apoptosis/cell death in leukemia cells Dec 28, 2008 Abandoned
Array ( [id] => 5342319 [patent_doc_number] => 20090180969 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-16 [patent_title] => 'PHARMACEUTICAL FORMULATION COMPRISING AN ANTICHOLINERGIC DRUG' [patent_app_type] => utility [patent_app_number] => 12/343931 [patent_app_country] => US [patent_app_date] => 2008-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5897 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20090180969.pdf [firstpage_image] =>[orig_patent_app_number] => 12343931 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/343931
PHARMACEUTICAL FORMULATION COMPRISING AN ANTICHOLINERGIC DRUG Dec 23, 2008 Abandoned
Array ( [id] => 6493577 [patent_doc_number] => 20100285960 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => ' METHOD FOR MODULATING THE RELEASE RATE OF MICROENCAPSULATED ACTIVES' [patent_app_type] => utility [patent_app_number] => 12/811515 [patent_app_country] => US [patent_app_date] => 2008-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6163 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20100285960.pdf [firstpage_image] =>[orig_patent_app_number] => 12811515 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/811515
METHOD FOR MODULATING THE RELEASE RATE OF MICROENCAPSULATED ACTIVES Dec 22, 2008 Abandoned
Array ( [id] => 5484863 [patent_doc_number] => 20090274628 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'RECONSTITUTABLE MICROSPHERE COMPOSITIONS USEFUL AS ULTRASONIC CONTRAST AGENTS' [patent_app_type] => utility [patent_app_number] => 12/329202 [patent_app_country] => US [patent_app_date] => 2008-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9001 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20090274628.pdf [firstpage_image] =>[orig_patent_app_number] => 12329202 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/329202
RECONSTITUTABLE MICROSPHERE COMPOSITIONS USEFUL AS ULTRASONIC CONTRAST AGENTS Dec 4, 2008 Abandoned
Array ( [id] => 6125622 [patent_doc_number] => 20110086080 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-14 [patent_title] => 'EX-VIVO PRODUCTION OF HUMAN DEMINERALIZED BONE MATRIX' [patent_app_type] => utility [patent_app_number] => 12/742810 [patent_app_country] => US [patent_app_date] => 2008-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8967 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20110086080.pdf [firstpage_image] =>[orig_patent_app_number] => 12742810 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/742810
EX-VIVO PRODUCTION OF HUMAN DEMINERALIZED BONE MATRIX Nov 13, 2008 Abandoned
Array ( [id] => 6340504 [patent_doc_number] => 20100247604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'METHOD OF TREATMENT OF CONNECTIVE TISSUES AND ORGANS AND USES OF SAID TISSUES AND ORGANS' [patent_app_type] => utility [patent_app_number] => 12/738501 [patent_app_country] => US [patent_app_date] => 2008-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2980 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20100247604.pdf [firstpage_image] =>[orig_patent_app_number] => 12738501 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/738501
METHOD OF TREATMENT OF CONNECTIVE TISSUES AND ORGANS AND USES OF SAID TISSUES AND ORGANS Oct 15, 2008 Abandoned
Array ( [id] => 5447118 [patent_doc_number] => 20090048344 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-19 [patent_title] => 'Pharmaceutical composition comprising 5-methyl-2-2\' (chloro-6\'-fluoroanilino phe nylacetic acid' [patent_app_type] => utility [patent_app_number] => 12/287231 [patent_app_country] => US [patent_app_date] => 2008-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1811 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20090048344.pdf [firstpage_image] =>[orig_patent_app_number] => 12287231 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/287231
Pharmaceutical composition comprising 5-methyl-2-2' (chloro-6'-fluoroanilino phe nylacetic acid Oct 6, 2008 Abandoned
Array ( [id] => 15068287 [patent_doc_number] => 10463609 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-11-05 [patent_title] => Dendrimers for sustained release of compounds [patent_app_type] => utility [patent_app_number] => 12/681516 [patent_app_country] => US [patent_app_date] => 2008-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 48 [patent_no_of_words] => 19781 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12681516 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/681516
Dendrimers for sustained release of compounds Oct 5, 2008 Issued
Array ( [id] => 6494918 [patent_doc_number] => 20100286038 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'FORMULATION CONTAINING CYCLIN-DEPENDENT KINASE INHIBITING COMPOUND AND METHOD OF TREATING TUMORS USING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/678320 [patent_app_country] => US [patent_app_date] => 2008-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12099 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20100286038.pdf [firstpage_image] =>[orig_patent_app_number] => 12678320 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/678320
FORMULATION CONTAINING CYCLIN-DEPENDENT KINASE INHIBITING COMPOUND AND METHOD OF TREATING TUMORS USING THE SAME Sep 15, 2008 Abandoned
Array ( [id] => 5272132 [patent_doc_number] => 20090075908 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'Agent For Strengthening Calcium Containing Tissue and Use Thereof' [patent_app_type] => utility [patent_app_number] => 12/210587 [patent_app_country] => US [patent_app_date] => 2008-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8905 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20090075908.pdf [firstpage_image] =>[orig_patent_app_number] => 12210587 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/210587
Agent for strengthening calcium containing tissue and use thereof Sep 14, 2008 Issued
Array ( [id] => 6505893 [patent_doc_number] => 20100260856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'CORE PARTICLE FOR PHARMACEUTICAL PREPARATION' [patent_app_type] => utility [patent_app_number] => 12/745851 [patent_app_country] => US [patent_app_date] => 2008-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8116 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20100260856.pdf [firstpage_image] =>[orig_patent_app_number] => 12745851 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/745851
Core particle for pharmaceutical preparation Sep 7, 2008 Issued
Menu